News

Odessa American4d
50 or older? The pneumococcal pneumonia vaccine is recommended for you
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...
Fierce Pharma5d
GSK kicks off Blenrep's market return with first myeloma combo nod in UK
GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...
STAT5d
GSK blood cancer therapy, once pulled from the market, is approved in the U.K.
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...
GSK reports Blenrep combinations approved by MHRA
GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is ...
Fierce Pharma5d
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
Zacks Investment Research on MSN5d
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...
Pharmaceutical Technology on MSN5d
ACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59
The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...